Alliance Healthcare Group Limited (HY2026) Financial Analysis

Alliance Healthcare Group Limited has released its condensed interim financial statements for the six months ended 31 December 2025 (HY2026). This article provides a structured analysis of the Group’s performance, key financial metrics, segmental developments, cash flows, and management commentary to guide investors.

Key Financial Metrics

^{*Inferred from financial trends and may not represent exact values as only HY data is provided.}

Historical Performance and Trends

Alliance Healthcare demonstrated solid revenue growth, up 11.6% year-over-year. Profitability improved substantially, with profit before tax soaring over five times and net profit attributable to owners jumping more than four times. The Group’s net asset value per share also continued its steady climb, reflecting the positive accumulation of retained earnings.

Segmental Developments and Commentary

• Managed Healthcare Solutions: Revenue rose 23.8%, mainly due to more programs, higher patient volume, and increased corporate clients.
• Specialist Care Services: Up 13.3%, supported by the launch of new specialist clinics.
• Mobile and Digital Health Services: Up 32.1%, driven by telemedicine and the MIC@Home program.
• GP Clinic Services: Up 10.9%, benefitting from higher demand and Healthier SG initiatives.
• Pharmaceutical Services: Down 14.3% due to the conclusion of certain supply arrangements and the absence of non-recurring orders.
• Other Income: Down S\$42,000, mainly due to lower government grants received.

Cash Flow and Financial Position

• Operating cash flows were strong at S\$6.85m, supporting investments and debt repayments.
• Investing activities consumed S\$1.1m, mainly for PPE and IT development.
• Financing activities used S\$3.1m, with repayments of lease liabilities, bank loans, and dividends paid.
• Cash balance at period end stood at S\$19.01m.
• Net asset value per share is up to 12.47 cents from 11.81 cents at prior year-end.

Exceptional Items and Related-Party Transactions

• No exceptional earnings or expenses were noted.
• Professional fees and manpower expenses with related parties are disclosed and appear in line with business expansion.

Dividend Policy and Share Capital

• A first & final one-tier dividend of S\$206,390 (0.10 cents per share) was paid in the period. No interim dividend is proposed for HY2026, as the Board will review capital needs after full-year results.
• No share buybacks, placements, or dilution occurred. Performance shares outstanding are 1,498,000, down from 1,926,000 a year ago.

Chairman’s Statement and Management Outlook

“Utilisation of our ecosystem continued to grow, with total visits increasing from 1.25 million in FY2024 to over 1.45 million in FY2025, reflecting strong and expanding demand for our network. Our mobile care subsidiary, JagaMe, currently supports five government hospitals under the Mobile Inpatient Care at Home (‘MIC@Home’) programme…
Notwithstanding these opportunities, challenges remain. Macroeconomic uncertainties and rising employee costs may weigh on growth and business performance. The Group will proactively review the performance of individual businesses within our Group to strengthen our financial performance. We will also continue to strengthen and expand our healthcare ecosystem and home-based care solutions to deliver better care at sustainable cost, with greater accessibility for patients.”

Tone: The Chairman’s statement is positive on growth and ecosystem utilisation, but tempered with caution regarding macroeconomic uncertainties and rising costs. The outlook is proactive but acknowledges headwinds.

Significant Events & Risks

• No asset revaluations, divestments, IPOs, or asset sales were noted during the period.
• No material legal, regulatory, or natural disasters reported.
• Management highlighted the impact of macroeconomic uncertainties and rising costs as key risks.

Conclusion and Investment Recommendations

Overall Assessment: Alliance Healthcare delivered strong financial results in HY2026, with robust revenue growth and a surge in profitability. The Group’s expansion in managed healthcare, digital health, and new specialist clinics is driving performance. Cash flows are healthy, and the balance sheet remains solid. However, the Group faces rising costs and economic uncertainties, and management has adopted a prudent stance regarding interim dividends and investments.

Recommendations

• If you are currently holding the stock:
  
  The strong earnings momentum and healthy financial position justify holding the stock, especially given the Group’s successful expansion and prudent management. Monitor cost pressures and macroeconomic developments in subsequent reports.
• If you are not currently holding the stock:
  
  Consider accumulating on weakness or after further confirmation of continued revenue and profit growth. The Group’s strategic positioning in managed healthcare, digital health, and its integrated ecosystem gives it a competitive edge, though rising costs are a watch point.

Disclaimer: This analysis is based solely on the attached interim financial report. It is not investment advice. Please consult a licensed adviser and consider your risk tolerance before making investment decisions.

View Alliance HC Historical chart here